About Dynakin
Dynakin is a company based in Derio (Spain) founded in 2004 was acquired by CTI Clinical Trial in July 2021. Dynakin offers products and services including DynaPred, Strategic Consulting, Bioanalytical Services, and Clinical Trial Services. Dynakin operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Precision for Medicine, among others.
- Headquarter Derio, Spain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dynakin S.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
CTI Clinical Trial
(Jul 14, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dynakin
Dynakin offers a comprehensive portfolio of products and services, including DynaPred, Strategic Consulting, Bioanalytical Services, and Clinical Trial Services.
Platform for personalized pharmacotherapy in drug development processes.
Provides strategic advice for pharmaceutical and regulatory strategies.
Offers testing and methods for drug analysis in clinical settings.
Manages services for clinical trials and related research activities.
Funding Insights of Dynakin
Detailed funding history for Dynakin
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Dynakin
Dynakin has secured backing from 1 investor. Prominent investors backing the company include CTI Clinical Trial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides clinical trials, consulting, and regulatory services in healthcare sectors.
|
Locked | Locked | Locked |
Investor details for Dynakin
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dynakin
Investment portfolio details for Dynakin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dynakin
Detailed financials for Dynakin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dynakin Comparisons
Peer comparison for Dynakin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dynakin
Dynakin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Precision for Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
|
| Locked | Locked | Locked |
Contract research organisation offering drug discovery, preclinical and clinical development services
|
Detailed competitors of Dynakin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dynakin
Complete news archive for Dynakin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dynakin
Dynakin was founded in 2004.
Dynakin is headquartered in Derio, Spain. It is registered at Derio, Pais Vasco, Spain.
DynaKin was established in 2004 in Derio, Spain, within the pharmaceutical and biotechnology sector. Services encompass translational drug development from pre-clinical phases to marketing. Clinical research support is extended for product development across Phases I through IV. Bioanalytical services are delivered for both non-clinical and clinical programs. Optimization of drug development processes is facilitated through pharmaceutical statistical models.
Dynakin's top competitors include LabCorp, Charles River Laboratories and Cytel.
Dynakin offers DynaPred, Strategic Consulting, Bioanalytical Services, and Clinical Trial Services.
Dynakin has 1 investor. Key investors include CTI Clinical Trial.